Richard Waines is an Investor at DCVC Bio.DCVC Bio invests in early-stage, deep-tech life science companies that are leveraging computational approaches, including AI and automation, to transform existing technologies and accelerate the development of new ones. Chapters/Takeaways03:19 → Journey into Biotech Investing11:53 → DCVC Bio's Focus and Investment Strategy16:19 → Exploring Platform Therapeutics in Biotech20:15 → Nuances of Biotech Investing vs. Other Industries23:11 → Managing Science Risk in Biotech Investments27:58 → Key Personnel Changes During Company Growth30:24 → Geographical Considerations in Biotech Investments34:30 → The Passion for Science vs. Business in Biotech36:08 → The Role of an Associate in Venture Capital41:17 → The Impact of AI on Biotech Investments

Ver todos los episodios